ArticleThe oncologist2025

Real-world evaluation of CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer: prognostic effect of proton pump inhibitor use.

Bo-Fang Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.